DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-8.37%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.26B
AUM Growth
-$1.44B
(-21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-22.76%
Top 10 Holdings %
Top 10 Hldgs %
53.77%
Holding
466
New
22
Increased
24
Reduced
24
Closed
360
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$87.7M |
| 2 |
Dynavax Technologies
DVAX
|
+$66M |
| 3 |
Oscar Health
OSCR
|
+$53.5M |
| 4 |
Legend Biotech
LEGN
|
+$50.5M |
| 5 |
Indivior
INDV
|
+$47.1M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$157M |
| 2 |
Kura Oncology
KURA
|
+$106M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$64.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$62.1M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Industrials | 0.23% |
| 3 | Consumer Staples | 0.01% |
| 4 | Energy | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Alamo Group
ALG
$2.5B
| – | – |
-5,148
| Closed | -$927K |
|
352
Autoliv
ALV
$9.63B
| – | – |
-3,548
| Closed | -$331K |
|
353
Amalgamated Financial
AMAL
$857M
| – | – |
-24,294
| Closed | -$762K |
|
354
Advanced Micro Devices
AMD
$259B
| – | – |
-1,932
| Closed | -$317K |
|
|
AMED
355
DELISTED
Amedisys
AMED
| – | – |
-10,072
| Closed | -$972K |
|
356
AMN Healthcare
AMN
$751M
| – | – |
-8,893
| Closed | -$377K |
|
357
Amplitude
AMPL
$1.48B
| – | – |
-127,474
| Closed | -$1.14M |
|
358
Alpha Metallurgical Resources
AMR
$1.85B
| – | – |
-2,319
| Closed | -$548K |
|
359
AMERISAFE
AMSF
$857M
| – | – |
-8,283
| Closed | -$400K |
|
360
Andersons Inc
ANDE
$1.37B
| – | – |
-28,632
| Closed | -$1.44M |
|
361
Aquestive Therapeutics
AQST
$590M
| – | – |
-155,145
| Closed | -$773K |
|
362
ArcBest
ARCB
$1.61B
| – | – |
-10,614
| Closed | -$1.15M |
|
363
Ardelyx
ARDX
$1.6B
| – | – |
-30,354
| Closed | -$209K |
|
364
Arrowhead Research
ARWR
$3.99B
| – | – |
-26,439
| Closed | -$512K |
|
365
ASGN Inc
ASGN
$2.23B
| – | – |
-2,911
| Closed | -$271K |
|
366
Astria Therapeutics
ATXS
$423M
| – | – |
-12,153
| Closed | -$134K |
|
|
AUTL
367
Autolus Therapeutics
AUTL
$367M
| – | – |
-3,639,000
| Closed | -$13.2M |
|
368
Broadcom
AVGO
$1.74T
| – | – |
-1,676
| Closed | -$289K |
|
|
JBIO
369
Jade Biosciences, Inc. Common Stock
JBIO
$247M
| – | – |
-40,332
| Closed | -$2.95M |
|
370
Anavex Life Sciences
AVXL
$763M
| – | – |
-105,484
| Closed | -$599K |
|
371
Boeing
BA
$172B
| – | – |
-3,123
| Closed | -$475K |
|
372
Banc of California
BANC
$2.65B
| – | – |
-65,140
| Closed | -$960K |
|
373
Barings BDC
BBDC
$994M
| – | – |
-102,058
| Closed | -$1M |
|
374
Becton Dickinson
BDX
$54B
| – | – |
-6,312
| Closed | -$1.52M |
|
375
Cencora
COR
$57.4B
| – | – |
-3,485
| Closed | -$784K |
|